Contact | Sitemap | Imprint | Login 
p53-Research - Home
p53-RESEARCH   

Home
Clinical Trials
About us
Research focus
About p53
Li-Fraumeni
Tumor bank
News
p53 Analysis
Links
Support

 

 

Home 

  

Medical University of Vienna

Surgical Research
Waehringer Guertel 18-20
1090 Vienna / Austria / Europe
Phone: +43 1 40400 6848 (lab)
Daniela.Kandioler@meduniwien.ac.at

 

  • Overall, fifty percent of patients currently do not benefit from standard cancer treatment.
  • Markers, identifying patients who will benefit from a certain treatment are urgently needed.
  • The p53 gene plays a crucial role in the way a tumour responds to chemotherapy.
  • The major task of our research group is to set out for the clinical application of p53 as predictive marker in cancer therapy.

 

 

04.04.2013
Thursday May 30th: p53 adaptierte noeadjuvante Chemotherapie: Daten der Ösophagus Pilot Studie und erster Bericht über die österreichische, prospektiv randomisierte PANCHO Studie
more>>
04.04.2013
Sat April 6th: To treat or not to treat: MARK53 predicts outcome of cancer patients
more>>
07.09.2012
Designing p53 Trials: A Surgical Oncologists View - Daniela Kandioler, Sonja Kappel, Brigitte Wolf
more>>


  © p53-Research printversion recommend this pagedeveloped by DATA TECHNOLOGY